"The Mechanic" Cellular Energy Optimization Protocol

Your cells make energy the same way they always have. A fuel source comes in, electrons get passed down a chain of proteins, and that movement drives the production of ATP, which is the chemical your body actually runs on. That system has not changed. What changes is how well the machinery holds up over time, and the answer is not well.

There are three places where that machinery tends to fail as you age, and understanding all three before we get into any intervention is the only way any of this makes sense.

The first failure point is the inner mitochondrial membrane itself. Your mitochondria produce ATP through a series of protein complexes called the electron transport chain, and those complexes are embedded in the inner membrane, which has to fold inward to create enough surface area for the job. Those folds are called cristae. The whole architecture depends on a specialized lipid called cardiolipin, which anchors the protein complexes in place and keeps the cristae tight. When cardiolipin gets damaged by oxidative stress over time, the cristae unfold, the complexes drift apart, and electrons start leaking out before they complete the chain. Leaked electrons react with oxygen and produce reactive oxygen species, which damage more cardiolipin, which causes more leaking. That is a self-reinforcing loop that is very hard to stop once it starts.

The second failure point is what happens to your NAD+. NAD+ is the molecule that accepts electrons at the beginning of the transport chain, and without enough of it, the whole system slows down. Research published in Cell Metabolism found that an enzyme called CD38 increases in activity two to three fold with age and is responsible for a substantial portion of the age-related decline in NAD+. The mechanism behind that increase was mapped out in a 2020 study in Nature Metabolism, which found that senescent cells, the dysfunctional cells that accumulate with age and refuse to die, release inflammatory signals that cause nearby immune cells to upregulate CD38. So the senescent cells are not just sitting there doing nothing. They are actively pulling down your NAD+ by programming the immune system to destroy it.

The third failure point is efficiency. Even when you have enough NAD+ and intact membranes, the machinery itself can become less productive. Coenzyme Q10, which functions as the mobile electron carrier between Complex I and Complex III in the chain, declines significantly with age. Without it, electrons cannot be handed off efficiently, and ATP output drops even if everything else is in order.

Those three failures compound each other, and that compounding is why addressing only one of them tends to produce underwhelming results.

The foundation before any of this is the unglamorous stuff: a quality multivitamin, zinc, fish oil, vitamin D3 with K2, and magnesium glycinate. Then creatine at five grams per day, which supports ATP regeneration directly, and CoQ10, which addresses that electron carrier decline. These are not exciting, but they are the floor everything else stands on.

The repair phase starts with SS-31, a compound that selectively binds to cardiolipin on the inner mitochondrial membrane. Research published in the Journal of the American Society of Nephrology showed that SS-31 stabilizes the cristae architecture, reduces electron leakage, and cuts reactive oxygen species production. The dose in the protocol is one to two milligrams per day for four to eight weeks, which is conservative relative to some research doses. The goal is to stop the cardiolipin damage loop before you do anything else, because trying to optimize mitochondria with compromised membranes is like trying to improve the gas mileage of a car with a cracked engine block.

After several weeks of SS-31, FOXO4-DRI comes in. Senescent cells survive by trapping a protein called p53 in a complex with another protein called FOXO4. P53 would normally trigger the cell to self-destruct, but FOXO4 holds it back. FOXO4-DRI is a peptide that disrupts that complex, freeing p53 to do its job. The 2017 Cell study by Baar and colleagues measured 11.73-fold selectivity for senescent cells over healthy cells, which matters because you want the dying cells gone without collateral damage to healthy tissue. The protocol calls for 2 to 5 milligrams every other day for three doses total. During those days, expect to feel off. That is your immune system clearing the cellular debris, and it passes.

Epithalon comes in after that, at 500 micrograms to one milligram per day for 10 to 20 days, one to two times per year. The research here is narrower than the SS-31 or FOXO4-DRI literature, so the confidence level is lower. A 2003 study found Epithalon induced expression of hTERT, the catalytic subunit of telomerase, in human fibroblasts, and achieved measurable telomere elongation. Whether that translates into the kind of functional improvements the protocol is targeting is less established, and you should hold that claim accordingly.

Once the repair phase is complete, the protocol transitions to MOTS-c, a peptide that is actually produced by the mitochondria themselves. MOTS-c activates something called AMPK, which is an energy-sensing enzyme that functions like a fuel gauge for the cell. When AMPK is active, the cell shifts toward more efficient energy production and upregulates pathways that support mitochondrial function. The 2015 Cell Metabolism study showed MOTS-c prevented diet-induced obesity and insulin resistance in mice through this AMPK activation. The dose in the protocol is 5 to 15 milligrams per week split into three injections. The logic of sequencing it after SS-31 is direct: MOTS-c pushes mitochondria to perform at a higher level, and that only pays off if the membranes are already stabilized.

For NAD+ support, the research on oral NMN and NR has shifted considerably. A 2025 study in Science Advances confirmed that most oral NMN and NR is converted to niacin-pathway metabolites in the gut before it ever reaches circulation, meaning the gut is doing the conversion work regardless of what precursor you start with. Niacin costs a fraction of a cent per dose and reaches the same endpoint. If injectable NAD+ is already part of your routine, it bypasses gut conversion, so it remains a reasonable option.

L-carnitine is worth understanding before deciding whether to add it. Long-chain fatty acids cannot cross the inner mitochondrial membrane on their own. L-carnitine is the only molecule that shuttles them across for beta-oxidation. If fatty acid metabolism is a limiting factor in your energy production, injectable L-carnitine at 200 to 500 milligrams three to five times per week addresses that gap. Whether it is a limiting factor depends on the individual.

One number that tends to get overlooked in this whole conversation: a 2010 study found that NAMPT, the rate-limiting enzyme in the main NAD+ biosynthesis pathway, increased by 127% in skeletal muscle after exercise training in previously sedentary subjects. Exercise does more for your NAD+ machinery than most supplements at most doses. The protocol is built to work alongside that biology, not instead of it.

The real insight here is that cellular energy is not a single dial you turn up. It is a system with a sequence, and the sequence matters more than any individual compound. Repairing damaged structure before trying to optimize output. Clearing dysfunctional cells before trying to restore the signaling environment. Understanding that the gut converts your expensive precursors into cheap ones before they ever reach a cell. The biology was already doing most of this work. The question is whether you are helping it or getting in its way.

---

References

1. Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;248:1250-1261. Finding: SS-31 selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure. Source
2. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014;1718:2029-2050. Finding: SS-31 binds cardiolipin, stabilizes mitochondrial membrane structure, and reduces electron leakage and ROS production. Source
3. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;1691:132-147. Finding: FOXO4-DRI disrupts FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis. 11.73-fold selectivity for senescent vs healthy cells. Source
4. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age. CD38 knockout mice maintained NAD+ levels at all ages. Source
5. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cell SASP cytokines induce macrophages to upregulate CD38, establishing the causal chain from senescence to NAD+ decline. Source
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;1356:590-592. Finding: Epithalon induced hTERT expression, telomerase activity, and telomere elongation in human fibroblasts. Source
7. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology. 2005;401-2:51-57. Finding: Epithalamin at 5mg/day and synthetic Epithalon at 10mcg/day achieved equivalent melatonin restoration in aged monkeys, demonstrating 500-fold potency difference. Source
8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;213:443-454. Finding: MOTS-c activates AMPK via inhibition of the folate cycle. Prevented insulin resistance and diet-induced obesity. Source
9. Shats I, Williams JG, Liu J, et al. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 2020;313:564-579. Finding: Gut bacteria deamidate nicotinamide to nicotinic acid niacin, confirming NMN/NR undergo gut conversion before absorption. Source
10. Kim LJ, et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. 2025. Finding: Most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption. Source
11. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. American Journal of Physiology - Endocrinology and Metabolism. 2010;2981:E117-E126. Finding: NAMPT protein increased 127% in sedentary subjects after exercise training. Source
12. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;186310:2422-2435. Finding: L-carnitine is the sole molecule carrying long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Source
13. Banerjee R, Purhonen J, Bhardwaj R, Bhargava A, Kallijarvi J. The mitochondrial coenzyme Q junction and complex III. The FEBS Journal. 2022;28922:6936-6958. Finding: CoQ serves as the mobile electron carrier between Complex I/II and Complex III. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness